Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.45
(-3.23%)
AUD 0.45
(-3.23%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13 Million | -12.68 Million | -9.01 Million | -7.85 Million | -3.8 Million | -2.61 Million |
| Net Income | -17.66 Million | -13.07 Million | -10.98 Million | -13.51 Million | -4.31 Million | -2.78 Million |
| Depreciation & Amortization | 366.76 Thousand | 217.15 Thousand | 187.67 Thousand | 295.63 Thousand | 200.81 Thousand | 56.08 Thousand |
| Deferred income taxes | - | 98.32 Thousand | -456.21 Thousand | -5.72 Million | -283.86 Thousand | - |
| Stock-based compensation | - | 325.21 Thousand | 256.48 Thousand | 5.21 Million | 55.2 Thousand | - |
| Change in working capital | 4.26 Million | -152.32 Thousand | 1.53 Million | 143.93 Thousand | 253.26 Thousand | -15.56 Thousand |
| Other non-cash items | -3.12 Million | -98.32 Thousand | 456.21 Thousand | 5.72 Million | 283.86 Thousand | 136.53 Thousand |
| Investing Cash Flow | -141.89 Thousand | -38.63 Thousand | -40.34 Thousand | -76 Thousand | -5944.00 | -89.93 Thousand |
| Investments in PPE | -141.89 Thousand | -38.63 Thousand | -40.34 Thousand | -76 Thousand | -5944.00 | -89.93 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 16 Million | 2.7 Million | -240.49 Thousand | 26.12 Million | 6.09 Million | 2.42 Million |
| Debt repayment | -5.88 Million | -2.87 Million | -139.17 Thousand | -174.7 Thousand | -737.4 Thousand | -734.54 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1.71 Million | -1.71 Million | - | - |
| Common Stock Issuance | 10.58 Million | 102.04 Thousand | 287.4 Thousand | 26.33 Million | 6.97 Million | 1.69 Million |
| Other Financing Activities | -162.96 Thousand | 5.48 Million | 3.04 Million | 3.39 Million | -150.1 Thousand | 1.46 Million |
| Accounts receivables | 60.79 Thousand | 91.8 Thousand | 63.01 Thousand | -204.12 Thousand | -4847.00 | -15.56 Thousand |
| Accounts payables | 3.81 Million | 766.04 Thousand | 112.61 Thousand | 284.42 Thousand | 177.82 Thousand | 88.61 Thousand |
| Inventory | - | - | - | 1.00 | - | -136.53 Thousand |
| Other working capital | 390.53 Thousand | -1.01 Million | 1.35 Million | 63.63 Thousand | 80.28 Thousand | 47.92 Thousand |
| Cash at beginning of period | 1.56 Million | 11.58 Million | 20.87 Million | 2.68 Million | 403.38 Thousand | 679.71 Thousand |
| Cash at end of period | 4.2 Million | 1.56 Million | 11.58 Million | 20.87 Million | 2.68 Million | 403.38 Thousand |
| Capital Expenditure | -141.89 Thousand | -38.63 Thousand | -40.34 Thousand | -76 Thousand | -5944.00 | -89.93 Thousand |
| Effect of forex changes on cash | - | 1.00 | 1.00 | - | - | - |
| Net cash flow / Change in cash | 2.64 Million | -10.02 Million | -9.29 Million | 18.19 Million | 2.27 Million | -276.33 Thousand |
| Free Cash Flow | -13.15 Million | -12.72 Million | -9.05 Million | -7.93 Million | -3.81 Million | -2.7 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.66 Million | -10.19 Million | -7.46 Million | -13.07 Million | -3.85 Million | -9.22 Million |
| Depreciation & Amortization | 366.76 Thousand | 173.48 Thousand | 193.28 Thousand | 217.15 Thousand | 141.87 Thousand | 75.28 Thousand |
| Deferred income taxes | - | - | - | 98.32 Thousand | - | - |
| Stock-based compensation | - | - | - | 325.21 Thousand | - | 325.21 Thousand |
| Change in working capital | 4.26 Million | - | - | -152.32 Thousand | -918.36 Thousand | - |
| Other non-cash items | -3.12 Million | 3.88 Million | 1.13 Million | -98.32 Thousand | 1.5 Million | -898.25 Thousand |
| Investing Cash Flow | -141.89 Thousand | -1653.00 | -140.24 Thousand | -38.63 Thousand | -428.91 Thousand | 390.28 Thousand |
| Investments in PPE | -141.89 Thousand | -35.62 Thousand | -106.27 Thousand | -38.63 Thousand | -34.18 Thousand | -4449.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 33.97 Thousand | -33.97 Thousand | - | -394.73 Thousand | 394.73 Thousand |
| Financing Cash Flow | 16 Million | 6.89 Million | 9.1 Million | 2.7 Million | 2.63 Million | 72.64 Thousand |
| Debt repayment | -5.88 Million | -7.36 Million | -1.48 Million | -2.87 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10.58 Million | -1985.00 | 10.58 Million | 102.04 Thousand | 29.4 Thousand | 72.64 Thousand |
| Other Financing Activities | -162.96 Thousand | -162.96 Thousand | 9.1 Million | 5.48 Million | -104.38 Thousand | 72.64 Thousand |
| Accounts receivables | 60.79 Thousand | - | - | 91.8 Thousand | 91.8 Thousand | - |
| Accounts payables | 3.81 Million | - | - | 766.04 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 390.53 Thousand | - | - | -1.01 Million | -1.01 Million | - |
| Cash at beginning of period | 1.56 Million | 4 Million | 1.56 Million | 11.58 Million | 1.84 Million | 11.58 Million |
| Cash at end of period | 4.2 Million | 4.2 Million | 4 Million | 1.56 Million | 1.56 Million | 1.84 Million |
| Capital Expenditure | -141.89 Thousand | -35.62 Thousand | -106.27 Thousand | -38.63 Thousand | -34.18 Thousand | -4449.00 |
| Effect of forex changes on cash | - | - | -1.00 | 1.00 | -1.56 Million | 11.58 Million |
| Net cash flow / Change in cash | 2.64 Million | 198.76 Thousand | 2.44 Million | -10.02 Million | -287.17 Thousand | -9.73 Million |
| Free Cash Flow | -13.15 Million | -6.52 Million | -6.62 Million | -12.72 Million | -2.52 Million | -10.2 Million |
ORKT
CVO
ARQQ
EIQ
SFM
APEX